C6A-62013-70906
2 vaccinations
1 coded response
13 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 111 / NY
- Registered
- 2021-01-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-12
Registered in v-safe
-
2021-01-12
Dose 1 — Pfizer-BioNTech
-
2021-01-12
Health check-in — day 0, dose 1Feeling: Good · Site: Pain · Fever · Fatigue or tirednessAdult check-in
-
2021-01-13
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fever · Fatigue or tirednessAdult check-in
- 2021-01-18
- 2021-01-28
-
2021-01-30
Dose 2 — Pfizer-BioNTech
- 2021-02-02
- 2021-02-04
- 2021-02-06
- 2021-02-20
- 2021-03-01
- 2021-03-06
- 2021-03-15
- 2021-05-03
-
2021-07-31
Survey response — 6 months, dose 2MedDRA: Pre-existing disease — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: DiabetesMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-07-31
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-03
- 2021-08-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-12 | Pfizer-BioNTech | |
| 2 | 2021-01-30 | Pfizer-BioNTech |
Call center
1 call center case
1 unsuccessful
Free text
Release 9 — 6 months, dose 2
Symptoms: Diabetes
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Pre-existing disease | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release